Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Stéphane Bancel
Pharma
Moderna CEO confronts challenges for RSV, COVID businesses
The changing COVID and RSV vaccine markets required Moderna to change part of its financial framework, CEO Stéphane Bancel explained to shareholders.
Angus Liu
Jan 7, 2025 11:00am
Moderna plots launch of its next potential mRNA vaccine approval
May 2, 2024 11:08am
Moderna's CEO takes slight pay cut during 'transition year'
Mar 12, 2024 10:47am
Moderna's CEO holds up to pressure at Senate hearing
Mar 23, 2023 11:45am
Moderna CEO Stéphane Bancel gets a $1.2M bump in pay to $19.4M
Mar 16, 2023 11:40am
Pharma could come under more Democrat scrutiny this year: report
Jan 23, 2023 2:27pm
